<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Article Tag Suite 1.1//EN"
  "https://jats.nlm.nih.gov/publishing/1.1/JATS-journalpublishing1.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink"
         xmlns:mml="http://www.w3.org/1998/Math/MathML"
         article-type="research-article"
         xml:lang="en">
  <front>
    <journal-meta>
      <journal-title-group>
        <journal-title>American Journal of PharmTech Research</journal-title>
        <abbrev-journal-title abbrev-type="publisher">AJPTR</abbrev-journal-title>
      </journal-title-group>
      <issn pub-type="epub">2249-3387</issn>
      <publisher>
        <publisher-name>undefined</publisher-name>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="doi">10.46624/ajptr.2019.v9.i2.013</article-id>
      <article-id pub-id-type="publisher-id">AJPTR92013</article-id>
      <title-group>
        <article-title>Atrigel-Implants and Controlled Release Drug Delivery System: A Review</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Thakare</surname>
            <given-names>Eknath B.</given-names>
          </name>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Malpure</surname>
            <given-names>Prashant S.</given-names>
          </name>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Maru</surname>
            <given-names>Avish D.</given-names>
          </name>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Surana</surname>
            <given-names>Santosh S.</given-names>
          </name>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Chavan</surname>
            <given-names>Bapu R.</given-names>
          </name>
        </contrib>
      </contrib-group>
      <pub-date pub-type="epub" iso-8601-date="2019-04-01">
        <month>04</month>
        <day>01</day>
        <year>2019</year>
      </pub-date>
      <volume>9</volume>
      <issue>2</issue>
      <abstract>
        <p>Parenteral delivery provides rapid onset even for the drug with narrow therapeutic window, but to maintain the systemic drug level repeated installation are required which cause the discomfort. Therefore, a delivery system that combines the simplicity and reliability of solid implant devices along with convenience and ease of administration on of micro-particles are desired. In situ gel forming system represents a desired alternate. The atrigel system is a proprietary delivery system that can be used for both parenteral and site specific drug delivery. it consist of biodegradable polymers dissolved in a biocompatible carriers when the liquid polymer system is placed in the body using standard needles and syringes, it solidifies upon contact with aqueous body fluids to form a solid implant. There are some advantages of these system are compatibility with a broad range of pharmaceutical compound, less invasive technique, direct delivery to a target area, protection of drug, sustained drug release, few type of atrigel are surgical implants, microspheres, liposomes and injectable gels.</p>
      </abstract>
      <kwd-group kwd-group-type="author">
        <kwd>Atrigel</kwd>
        <kwd>Biodegradable Polymer</kwd>
        <kwd>In Situ Gel Forming System</kwd>
        <kwd>Implants.</kwd>
      </kwd-group>
    </article-meta>
  </front>
  <body>
    <!-- Full article body not available in metadata-only JATS export. See PDF/HTML galley. -->
  </body>
  <back/>
</article>
